Chihiro Namatame¹, Tatsuro Misu¹, Yoichiro Abe², Yuki Matsumoto¹, Yoshiki Takai¹, Kazuo Fujihara³, Masato Yasui², Masashi Aoki¹ (1.Department of Neurology, Tohoku University School of Medicine, Japan, 2.Department of Pharmacology, Keio University Graduate School of Medicine, Japan, 3.Department Multiple Sclerosis & Therapeutics, Fukushima Medical University, Japan)

Youwei Lin^1,2, Shun Sakuraba³, Yoshimasa Tanaka⁴, Takashi Yamamura¹ (1.Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Japan, 2.Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Japan, 3.National Institutes for Quantum Science and Technology, Institute for Quantum Life Science, Japan, 4.Center for Medical Innovation, Nagasaki University, Japan)

Yue Hu¹, Yinan Zhao² (1.the First Hospital of China Medical University, China, 2.Xuanwu Hospital, National Center for Neurological Disorders, Capital Medical University, China)

Theodora C.E. Adeodatia, Evelyn N. Hailianto, Keshia P. Sugiono, Riona Sutanto (Faculty of Medicine Pelita Harapan University, Tangerang, Indonesia)

Takafumi Uchi, Shingo Konno, Hideo Kihara, Toshiki Fujioka (Toho University Ohashi Medical Center, Japan)

Maimaitijiang Guzailiayi¹, Jun-ichi Kira^1,2,3, Ayako Sakoda^1,2, Mitsuru Watanabe⁴, Satoshi Nagata⁴, Ezgi Ozdemir⁴, Katsuhisa Masaki⁴, Ryo Yamasaki⁴, Noriko Isobe⁴, Xu Zhang¹, Tomohiro Imamura^1,3, Yuri Nakamura^1,2,3 (1.Translational Neuroscience Research Center, Graduate School of Medicine, International University of Health and Welfare, Okawa, Japan, 2.Department of Neurology, Brain and Nerve Center, Fukuoka Central Hospital, International University of Health and Welfare, Fukuoka, Japan, Japan, 3.School of Pharmacy at Fukuoka, International University of Health and Welfare, Okawa, Japan, Japan, 4.Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan, Japan)